Sign Out
Regular consultation with a healthcare provider is recommended while using Medroxyprogesterone Acetate (LYNDAVEL). Inform the healthcare provider if the patient is suffering from the following conditions: cardiac or renal impairment; epilepsy; asthma; past ectopic pregnancy; history of depression; diabetes mellitus; hypertension; migraine; thromboembolism; other conditions which may be aggravated by fluid retention; conditions that cause significant decrease in bone mineral density that may lead to osteoporotic fractures.
Breastfeeding women should wait six weeks after giving birth before the administration of Medroxyprogesterone Acetate (LYNDAVEL).
Continue with Google